Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Rigel Pharmaceuticals

Rigel Pharmaceuticals reported $45.52M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Agenus AGEN:US USD 190.9M 1.95M
Amgen AMGN:US USD 14.22B 1.47B
Anika Therapeutics ANIK:US USD 28.69M 779K
Arrowhead Research ARWR:US USD 87.15M 34.86M
AstraZeneca AZN:LN USD 24.86B 1.43B
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Celldex Therapeutics CLDX:US USD 15.22M 3.39M
Daiichi Sankyo 4568:JP JPY 530.26B 73.2B
Eli Lilly LLY:US USD 16.01B 1.13B
Halozyme Therapeutics HALO:US USD 91.92M 38.87M
Heron Therapeutics HRTX:US USD 77.9M 4.46M
Immunogen IMGN:US USD 101.63M 20.23M
Intrexon XON:US USD 46.73M 31.91M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Karyopharm Therapeutics KPTI:US USD 61.56M 10.45M
Ligand Pharmaceuticals LGND:US USD 98.93M 119K
MacroGenics MGNX:US USD 45.61M 3M
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Rigel Pharmaceuticals RIGL:US USD 45.52M 19.69M
Sangamo BioSciences SGMO:US USD 57.84M 53.87M
Ultragenyx Pharmaceutical RARE:US USD 218.18M 43.03M
Veracyte VCYT:US USD 55.99M 6.62M